The treatment of Parkinson's disease with levodopa has been discussed...
Published Thursday 04 December 2008
Annual report finds cancer initiative a success
A new initiative that aims to improve the treatment of...
Published Thursday 04 December 2008
New game could help tackle obesity and diabetes in kids, expert claims
A new scheme from the British Heart Foundation (BHF) will...
Published Thursday 04 December 2008
Some "good cholesterol" not good enough, study suggests
A number of preconceptions about "good" HDL cholesterol have been...
Published Tuesday 02 December 2008
More Medical News
27 Aug 2008
A study referred to as the "twins trial" has suggested that taking 1,000mg of an olive leaf extract can lower cholesterol and blood pressure in patients who have mild hypertension.
Published in the latest edition of Phytotherapy Research, the study saw researchers from Germany and Switzerland carry out a trial with 20 monozygotic twin pairs who had increased blood pressure.
It was noted that previous studies carried out on rats found that olive leaf extract was a potential treatment for lowering blood pressure.
The twins were assigned to receive different treatments and were either given capsules containing 500mg or 1,000mg of olive leaf extract EFLA943, or a placebo.
After the subjects had taken their treatment for a period of eight weeks, the researchers measured their blood pressure and collected data about their lifestyles.
General manager of Frutarom Health Cem Aydogan comments: "The study confirmed that olive leaf extract EFLA943 has antihypertensive properties in humans. This work showed that taking a 1,000mg dose has substantial effects in people with borderline hypertension."
Login and visit the Cholesterol Knowledge Centre
- New game could help tackle obesity and diabetes in kids, expert claims 04/12/08
- Some "good cholesterol" not good enough, study suggests 02/12/08
- Study links grapes with reduced cardio risk 29/10/08
- Statins could prevent arterial ageing, study suggests 29/09/08
- Higher doses of statins may affect skeletal muscle regeneration, study suggests 25/09/08

Medical News
![The NSCLCs account for 80% of all lung cancers and can be further subdivided into squamous-cell carcinoma, large-cell carcinoma and adenocarcinoma (which includes bronchioloalveolar-cell carcinoma [BAC] The NSCLCs account for 80% of all lung cancers and can be further subdivided into squamous-cell carcinoma, large-cell carcinoma and adenocarcinoma (which includes bronchioloalveolar-cell carcinoma [BAC]](/images/banners/nsclc.gif)


